Open AccessHigh On-Treatment Platelet Reactivity Determinants on Dual Antiplatelet Therapy in Patients With Ischemic Heart Disease Before Elective Percutaneous Coronary Intervention
Author(s) -
Е.З. Голухова,
Marina V. Grigoryan,
Mariya N. Ryabinina,
Naida I. Bulaeva
Publication year - 2018
Publication title -
kardiologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.159
H-Index - 16
eISSN - 2412-5660
pISSN - 0022-9040
DOI - 10.18087/cardio.2018.4.10104
Subject(s) - medicine , clopidogrel , percutaneous coronary intervention , cyp2c19 , body mass index , von willebrand factor , aspirin , conventional pci , gastroenterology , cardiology , univariate analysis , platelet , myocardial infarction , multivariate analysis , cytochrome p450 , metabolism
to determine impact of different laboratory and genetic factors on high on-treatment platelet reactivity (HOPR) during dual antiplatelet therapy (DAPT).